Rosso R - Search Results

1

Rapid development of resistance to antifolates in vitro: possible clinical implication.

Sobrero A, Aschele C, Rosso R, Nicolin A, Bertino JR. Sobrero A, et al. Among authors: rosso r. J Natl Cancer Inst. 1991 Jan 2;83(1):24-8. doi: 10.1093/jnci/83.1.24. J Natl Cancer Inst. 1991. PMID: 1824599

2

Improved therapeutic index of cisplatin by procaine hydrochloride.

Esposito M, Fulco RA, Collecchi P, Zicca A, Cadoni A, Merlo F, Rosso R, Sobrero A. Esposito M, et al. Among authors: rosso r. J Natl Cancer Inst. 1990 Apr 18;82(8):677-84. doi: 10.1093/jnci/82.8.677. J Natl Cancer Inst. 1990. PMID: 2319610

3

Sequence-dependent enhancement of HCT-8 cell kill by trimetrexate and fluoropyrimidines: implications for the mechanism of this interaction.

Sobrero A, Romanini A, Russello O, Nicolin A, Rosso R, Bertino JR. Sobrero A, et al. Among authors: rosso r. Eur J Cancer Clin Oncol. 1989 Jun;25(6):977-82. doi: 10.1016/0277-5379(89)90157-0. Eur J Cancer Clin Oncol. 1989. PMID: 2526736

4

Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.

Sobrero AF, Aschele C, Guglielmi AP, Mori AM, Melioli GG, Rosso R, Bertino JR. Sobrero AF, et al. Among authors: rosso r. J Natl Cancer Inst. 1993 Dec 1;85(23):1937-44. doi: 10.1093/jnci/85.23.1937. J Natl Cancer Inst. 1993. PMID: 8230285

5

Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study.

Aschele C, Guglielmi A, Frassineti GL, Milandri C, Amadori D, Labianca R, Vinci M, Tixi L, Caroti C, Ciferri E, Verdi E, Rosso R, Sobrero A. Aschele C, et al. Among authors: rosso r. Br J Cancer. 1998;77(2):341-6. doi: 10.1038/bjc.1998.53. Br J Cancer. 1998. PMID: 9461008 Free PMC article. Clinical Trial.

6

Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implications.

Sobrero A, Aschele C, Guglielmi A, Nobile MT, Rosso R. Sobrero A, et al. Among authors: rosso r. J Chemother. 1990 Feb;2 Suppl 1:12-6. doi: 10.1080/1120009x.1990.11738999. J Chemother. 1990. PMID: 2142213

7

Comparison of in vitro drug sensitivity by inhibition of tritium release from [5-3H]-2'-deoxyuridine and a clonogenic assay.

Aschele C, Romanini A, Nicolin A, Rosso R, Sobrero A. Aschele C, et al. Among authors: rosso r. Anticancer Res. 1990 May-Jun;10(3):759-64. Anticancer Res. 1990. PMID: 2195987

8

Cell kinetics in ovarian cancer. Relationship to clinicopathologic features, responsiveness to chemotherapy, and survival.

Conte PF, Alama A, Rubagotti A, Chiara S, Nicolin A, Nicolò, Rosso R, Gaddi M, Ghiringhello B, Tomao S, et al. Conte PF, et al. Among authors: rosso r. Cancer. 1989 Sep 15;64(6):1188-91. doi: 10.1002/1097-0142(19890915)64:6<1188::aid-cncr2820640604>3.0.co;2-5. Cancer. 1989. PMID: 2766216

9

5-Fluorouracil plus 5-methyltetrahydrofolate in advanced pancreatic cancer. GLISP (Gruppo Ligure Studio Pancreas).

Bolli E, Saccomanno S, Mondini G, Aschele C, Guglielmi A, Ligas B, Connio M, Mori A, Rosso R, Sobrero A, et al. Bolli E, et al. Among authors: rosso r. Cancer Chemother Pharmacol. 1995;35(4):339-42. doi: 10.1007/BF00689455. Cancer Chemother Pharmacol. 1995. PMID: 7828278 Clinical Trial.

10

Activity of continuous-infusion 5-fluorouracil in patients with advanced colorectal cancer clinically resistant to bolus 5-fluorouracil.

Mori A, Bertoglio S, Guglielmi A, Aschele C, Bolli E, Tixi L, Rosso R, Sobrero A. Mori A, et al. Among authors: rosso r. Cancer Chemother Pharmacol. 1993;33(2):179-80. doi: 10.1007/BF00685339. Cancer Chemother Pharmacol. 1993. PMID: 8261580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

868 results

Search Page

Filters